INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 48m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
Public company

BLCOBausch & Lomb Corp

CIK 0001860742

EDGAR filingsOpen in network
Disclosed transactions41
Buys / sells0 / 2
Max Insider Score39
Connections21with evidence

BLCO · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
MF
Munsch FrederickSVP, Controller and CAO
BLCOBausch & Lomb Corp
Option exercise
M—
87.9K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3851 · Ophthalmic Goods · Nov 4, 2026
  • ← Lobbied forevidence
    H.A. CUMBER & COMPANY, INC.LDA Q2 2026 second quarter · MED, Pharmacy · Aug 26, 2026
  • ← Insider ofevidence
    Trebbi BarbaraDirector · Aug 14, 2026
  • ← Insider ofevidence
    Paul Laurence EDirector · Aug 14, 2026
5
MF
Munsch FrederickSVP, Controller and CAO
BLCOBausch & Lomb Corp
Option exercise
M
—
24.1K sh
Oct 29, 2026
Nov 2, 2026
traded Oct 29, 2026
+4d
SEC FORM 4

Evidence

9
RC
Robertson Russel CDirector
BLCOBausch & Lomb Corp
Grant or award
A$26K
1,256 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

9
PJ
Paulson JohnDirector
BLCOBausch & Lomb Corp
Grant or award
A$23K
1,125 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

9
AE
Alfonso EduardoDirector
BLCOBausch & Lomb Corp
Grant or award
A$23K
1,125 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

23
MF
Munsch FrederickSVP, Controller and CAO
BLCOBausch & Lomb Corp
Option exercise
M$433K
24.1K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

26
MF
Munsch FrederickSVP, Controller and CAO
BLCOBausch & Lomb Corp
Option exercise
M$1.58M
87.9K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

38
MF
Munsch FrederickSVP, Controller and CAO
BLCOBausch & Lomb Corp
Open-market sale
SELL$2.29M
112.0K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC FORM 4

Evidence

9
TB
Trebbi BarbaraDirector
BLCOBausch & Lomb Corp
Grant or award
A—
11.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

9
CJ
Chersi Robert JDirector
BLCOBausch & Lomb Corp
Grant or award
A—
11.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

9
PE
Paul Laurence EDirector
BLCOBausch & Lomb Corp
Grant or award
A—
11.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

39
MF
Munsch FrederickSVP, Controller and CAO
BLCOBausch & Lomb Corp
Open-market sale
SELL$888K
52.9K sh
Aug 10, 2026Aug 12, 2026
traded Aug 10, 2026
+2dSEC FORM 4

Evidence

17
SL
Saunders Brent LDirector, Chairman of the Board and CEO
BLCOBausch & Lomb Corp
Grant or award
A—
281.9K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

13
SJ
Stewart Andrew J.President, GPIC
BLCOBausch & Lomb Corp
Grant or award
A—
16.8K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

13
MF
Munsch FrederickSVP, Controller and CAO
BLCOBausch & Lomb Corp
Grant or award
A—
9,091 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

13
HY
Hashad YehiaEVP of R&D and CMO
BLCOBausch & Lomb Corp
Grant or award
A—
21.0K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

13
ES
Eldessouky SamEVP and CFO
BLCOBausch & Lomb Corp
Grant or award
A—
50.3K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

13
BL
Bonnefoy LucPresident, Surgical
BLCOBausch & Lomb Corp
Grant or award
A—
16.8K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

13
BD
Bailey A Robert DEVP & Chief Legal Officer
BLCOBausch & Lomb Corp
Grant or award
A—
33.6K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

12
SL
Saunders Brent LDirector, Chairman of the Board and CEO
BLCOBausch & Lomb Corp
Tax withholding
F$71K
4,231 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

9
BL
Bonnefoy LucPresident, Surgical
BLCOBausch & Lomb Corp
Tax withholding
F$15K
1,008 sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC FORM 4

Evidence

20
VC
Von Eschenbach Andrew C.Director
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

20
LK
Ling KarenDirector
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

20
RC
Robertson Russel CDirector
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

20
RW
Ross Thomas W. Sr.Director
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

24
AE
Alfonso EduardoDirector
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

20
BD
Bernier Nathalie D.Director
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

24
CH
Collis Steven HDirector
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

20
PJ
Paulson JohnDirector
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

20
KB
Kavanagh Sarah BDirector
BLCOBausch & Lomb Corp
Grant or award
A$250K
15.8K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

9
SL
Saunders Brent LDirector, Chairman of the Board and CEO
BLCOBausch & Lomb Corp
Tax withholding
F$46K
2,886 sh
May 22, 2026May 26, 2026
traded May 22, 2026
+4dSEC FORM 4

Evidence

26
ES
Eldessouky SamEVP and CFO
BLCOBausch & Lomb Corp
Tax withholding
F$1.02M
63.9K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC FORM 4

Evidence

16
HY
Hashad YehiaEVP of R&D and CMO
BLCOBausch & Lomb Corp
Tax withholding
F$219K
13.7K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC FORM 4

Evidence

16
MF
Munsch FrederickSVP, Controller and CAO
BLCOBausch & Lomb Corp
Tax withholding
F$139K
8,673 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC FORM 4

Evidence

16
BL
Bonnefoy LucPresident, Surgical
BLCOBausch & Lomb Corp
Tax withholding
F$192K
12.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC FORM 4

Evidence

13
CH
Collis Steven HDirector
BLCOBausch & Lomb Corp
Grant or award
A$22K
1,415 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

9
PJ
Paulson JohnDirector
BLCOBausch & Lomb Corp
Grant or award
A$22K
1,375 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

13
AE
Alfonso EduardoDirector
BLCOBausch & Lomb Corp
Grant or award
A$22K
1,375 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

9
RC
Robertson Russel CDirector
BLCOBausch & Lomb Corp
Grant or award
A$26K
1,611 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

16
SJ
Stewart Andrew J.President, GPIC
BLCOBausch & Lomb Corp
Tax withholding
F$67K
4,216 sh
Apr 24, 2026Apr 27, 2026
traded Apr 24, 2026
+3dSEC FORM 4

Evidence

19
BD
Bailey A Robert DEVP & Chief Legal Officer
BLCOBausch & Lomb Corp
Tax withholding
F$250K
15.8K sh
Apr 24, 2026Apr 27, 2026
traded Apr 24, 2026
+3dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Chersi Robert JDirector · Aug 14, 2026
  • ← Insider ofevidence
    Kavanagh Sarah BDirector · May 28, 2026
  • ← Insider ofevidence
    Ross Thomas W. Sr.Director · May 28, 2026
  • ← Insider ofevidence
    Ling KarenDirector · May 28, 2026
  • ← Insider ofevidence
    Von Eschenbach Andrew C.Director · May 28, 2026
  • ← Insider ofevidence
    Bernier Nathalie D.Director · May 28, 2026
  • ← Insider ofevidence
    Saunders Brent LDirector, Chairman of the Board and CEO · May 26, 2026
  • ← Insider ofevidence
    Eldessouky SamEVP and CFO · May 7, 2026
  • ← Insider ofevidence
    Hashad YehiaEVP of R&D and CMO · May 7, 2026
  • ← Insider ofevidence
    Bonnefoy LucPresident, Surgical · May 7, 2026
  • ← Insider ofevidence
    Munsch FrederickSVP, Controller and CAO · May 7, 2026
  • ← Insider ofevidence
    Paulson JohnDirector · May 1, 2026
  • ← Insider ofevidence
    Robertson Russel CDirector · May 1, 2026
  • ← Insider ofevidence
    Alfonso EduardoDirector · May 1, 2026
  • ← Insider ofevidence
    Collis Steven HDirector · May 1, 2026
  • ← Insider ofevidence
    Bailey A Robert DEVP & Chief Legal Officer · Apr 27, 2026
  • ← Insider ofevidence
    Stewart Andrew J.President, GPIC · Apr 27, 2026

    • Lobbying

    $30K reported · de-duplicated
    2026 Q2 $30K via firms
    • H.A. CUMBER & COMPANY, INC.—2026 Q2 · posted Aug 26, 2026 · MED, Pharmacy
    • H.A. CUMBER & COMPANY, INC.$30K2026 Q2 · posted Aug 26, 2026 · MED, Pharmacy

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.